Close

Neovasc (NVCN) Updates on Tiara TMV Program; Reports Technical Success Rate of 86%

December 6, 2016 7:07 AM EST Send to a Friend
Neovasc Inc. (Nasdaq: NVCN) provided an update on the clinical experience with its Tiara transcatheter mitral valve. Tiara is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login